Adverse Drug Reaction Classification System

         

ADR Ontology
ADR Term Haemolytic anaemia
ADR ID BADD_A01933
ADR Hierarchy
01      Blood and lymphatic system disorders
01.06      Haemolyses and related conditions
01.06.03      Anaemias haemolytic NEC
01.06.03.002      Haemolytic anaemia
Description A condition of inadequate circulating red blood cells (ANEMIA) or insufficient HEMOGLOBIN due to premature destruction of red blood cells (ERYTHROCYTES). | Acquired anemia due to destruction of red blood cells by physical trauma such as FIBRIN strands in the blood vessels, artificial heart valve, AORTIC COARCTATION. I can also be associated with hematologic diseases such as DISSEMINATED INTRAVASCULAR COAGULATION; HEMOLYTIC-UREMIC SYNDROME; and THROMBOTIC THROMBOCYTOPENIC PURPURA. [MeSH]
MedDRA Code 10018916
MeSH ID D000743
ADR Severity Grade (FAERS)
ADR Severity Grade (CTCAE) Not Available
Synonym
Acquired haemolytic anaemia | Acquired haemolytic anaemia, unspecified | Acquired haemolytic anaemias | Acquired hemolytic anemia, unspecified | Acquired hemolytic anemias | Anaemia haemolytic | Anaemia primaquine sensitivity | Anemia hemolytic (NOS) | Anemia hemolytic occult | Anemia primaquine sensitivity type | Haemolytic anaemia | Haemolytic anaemia acquired | Haemolytic anaemia drug-induced | Haemolytic anaemia NOS | Hemolytic anemia | Hemolytic anemia (NOS) | Hemolytic anemia with antidrug antibody | Non-autoimmune haemolytic anaemia | Non-autoimmune haemolytic anaemias | Non-autoimmune hemolytic anemia, unspecified | Non-autoimmune hemolytic anemias | Other non-autoimmune hemolytic anemias | Primaquine sensitivity anaemia | Primaquine sensitivity anemia | Acquired hemolytic anemia | Anemia hemolytic | Hemolytic anemia acquired | Hemolytic anemia drug-induced | Non-autoimmune hemolytic anemia | Anaemia haemolytic occult | Haemolytic anaemia with antidrug antibody | Non-autoimmune haemolytic anaemia, unspecified | Anaemia primaquine sensitivity type | Acute hemolytic anemia | Acute haemolytic anaemia | Anemia, Hemolytic | Hemolytic Anemia | Microangiopathic Hemolytic Anemia | Anemia, Hemolytic, Acquired | Hemolytic Anemia, Acquired | Acquired Hemolytic Anemia | Anemia, Acquired Hemolytic | Anemia, Microangiopathic | Microangiopathic Anemia
Drugs Leading to the ADR
Drug IDDrug NameADR Frequency (FAERS)ADR Severity Grade (FAERS)
BADD_D02180Tetracycline anion--
BADD_D02181Tetracycline hydrochloride--
BADD_D02192Thalidomide0.000241%
BADD_D02204Thiothixene--
BADD_D02215Ticlopidine--
BADD_D02216Ticlopidine hydrochloride--
BADD_D02238Tolazamide--
BADD_D02240Tolbutamide--
BADD_D02242Tolmetin sodium--
BADD_D02254Tramadol--
BADD_D02259Trandolapril--
BADD_D02266Trazodone--
BADD_D02267Trazodone hydrochloride--
BADD_D02276Triamterene hydrochlorothiazide--
BADD_D02281Trifluoperazine--
BADD_D02282Trifluoperazine hydrochloride--
BADD_D02290Trimethoprim--
BADD_D02321Ursodiol--
BADD_D02344Vemurafenib0.000168%
BADD_D02345Venetoclax0.000951%
BADD_D02346Venlafaxine--
BADD_D02348Verapamil--
BADD_D02367Voltaren--
BADD_D02369Voriconazole--
BADD_D02375Water--
BADD_D02383Zidovudine--
BADD_D02398Zuclopenthixol--
BADD_D02464Fingolimod0.001567%
BADD_D02470Nintedanib0.000112%
BADD_D02471Oxygen0.001239%
The 12th Page    First    Pre   12 13    Next   Last    Total 13 Pages
ADReCS-Target
ADR Term Drug Name Target